See the science behind Oxiceutics®

Oxiceutics® is built on research from Realize Therapeutics. We’re focused on specific microbes, distinct probiotic strains and specialized formulations designed to fit into your routine.

LRDR™ L. reuteri

Our proprietary strain of Limosilactobacillus reuteri.

When it comes to probiotics like L. reuteri, the strain you're taking matters. Not every strain has been produced, developed or studied in the same way.

Since 2022, LRDR™ L. reuteri has been made available across a growing range of Oxiceutics® products.

The proprietary LRDR™ strain of L. reuteri was evaluated in a randomized, double-blind, placebo-controlled human study. Realize’s research continues.

  • From Realize Therapeutics

    LRDR™ is the proprietary L. reuteri strain from Realize Therapeutics—the company behind Oxiceutics®.

  • Clinically studied

    The proprietary LRDR™ strain of L. reuteri was evaluated in a randomized, double-blind, placebo-controlled human study.

  • Sourced in the USA

    LRDR™, our L. reuteri strain, is sourced in the USA.

The Oxiceutics approach

Not found in every gut.

Lactobacillus reuteri was once a common resident of the human gut, but modern factors have reduced its presence in many adults. Presence and levels vary widely between individuals.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

The research

What “studied” means, product by product.

Some of our products were studied as complete formulas. Others contain a strain that was studied on its own. We keep the two apart, so you know exactly what the research covers.

Studied as a complete formula

The finished formula was evaluated in a human study.

  • MyReuteri Shape™

    Evaluated as a Complete Formulation in a Randomized, Double-Blind, Placebo-Controlled Human Study

  • Gut to Glow®

    Evaluated as a Complete Formulation in a Controlled Human Trial

Contains a studied strain

The LRDR™ strain was studied. The finished products were not.

  • MyReuteri®

    The proprietary LRDR™ strain of L. reuteri was evaluated in a randomized, double-blind, placebo-controlled human study.

  • MyCrispatus® +

    LRDR™ was evaluated in a randomized, double-blind, placebo-controlled human study.

No product-level study

We don’t describe these products in terms of clinical research.

  • D&O Glow®

    No product-level study

  • Starter cultures

    Foods for making cultured dairy at home. They aren’t described in terms of clinical research.